SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity. — Quantapedia

PubMed: SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity.. Published 2022 May 23. Source: J Chem Inf Model. Authors: Golcuk M, Hacisuleyman A, Yilmaz SZ.

Powered by Quantum Pulse Intelligence